The belle detector
…, H Ikeda, H Ikeda, R Itoh, M Iwai, H Iwasaki… - Nuclear Instruments and …, 2002 - Elsevier
… Fujii b , Y. Fujita b , Y. Funahashi b , J. … BGO test crystal 1 received a dose of 115 krad in 1
h at its front surface. The time dependence of the relative output is shown before and after the …
h at its front surface. The time dependence of the relative output is shown before and after the …
[HTML][HTML] Immune evasion in cancer: Mechanistic basis and therapeutic strategies
…, A Bilsland, D Bhakta, D Halicka, H Fujii… - Seminars in cancer …, 2015 - Elsevier
Cancer immune evasion is a major stumbling block in designing effective anticancer
therapeutic strategies. Although considerable progress has been made in understanding how …
therapeutic strategies. Although considerable progress has been made in understanding how …
[HTML][HTML] Heavy-flavour and quarkonium production in the LHC era: from proton–proton to heavy-ion collisions
…, A Dainese, M Djordjevic, EG Ferreiro, H Fujii… - The European Physical …, 2016 - Springer
This report reviews the study of open heavy-flavour and quarkonium production in high-energy
hadronic collisions, as tools to investigate fundamental aspects of Quantum …
hadronic collisions, as tools to investigate fundamental aspects of Quantum …
Observation of Large Violation in the Neutral Meson System
We present a measurement of the standard model CP violation parameter sin 2 φ 1 based
on a 29.1 fb− 1 data sample collected at the ϒ (4 S) resonance with the Belle detector at the …
on a 29.1 fb− 1 data sample collected at the ϒ (4 S) resonance with the Belle detector at the …
Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
…, T Ikawa, H Kawamoto, J Furusawa, M Ohtani, H Fujii… - Nature, 2010 - nature.com
… are shared by NK cells, a T H 1 type innate lymphocyte subset. Hence, we propose that
FALC c-Kit + Sca-1 + IL7Rα + T1/ST2 + cells are T H 2 type innate lymphocytes and that this …
FALC c-Kit + Sca-1 + IL7Rα + T1/ST2 + cells are T H 2 type innate lymphocytes and that this …
Platinum catalysts for the high-yield oxidation of methane to a methanol derivative
…, DJ Taube, S Gamble, H Taube, T Satoh, H Fujii - Science, 1998 - science.org
… 4 and the methyl C–H bonds of methyl bisulate when a solution of CH 3 OSO 3 H (0.2 M) …
limiting rate of H/D exchange of methyl bisulfate (if we assume that all C–H activation events of …
limiting rate of H/D exchange of methyl bisulfate (if we assume that all C–H activation events of …
Abscisic acid inhibits type 2C protein phosphatases via the PYR/PYL family of START proteins
SY Park, P Fung, N Nishimura, DR Jensen, H Fujii… - science, 2009 - science.org
Type 2C protein phosphatases (PP2Cs) are vitally involved in abscisic acid (ABA) signaling.
Here, we show that a synthetic growth inhibitor called pyrabactin functions as a selective …
Here, we show that a synthetic growth inhibitor called pyrabactin functions as a selective …
Belle II technical design report
…, A Frey, M Friedl, R Fruehwirth, H Fujii… - arXiv preprint arXiv …, 2010 - arxiv.org
The Belle detector at the KEKB electron-positron collider has collected almost 1 billion Y(4S)
events in its decade of operation. Super-KEKB, an upgrade of KEKB is under construction, …
events in its decade of operation. Super-KEKB, an upgrade of KEKB is under construction, …
A critical analysis of the impacts of COVID-19 on the global economy and ecosystems and opportunities for circular economy strategies
The World Health Organization declared COVID-19 a global pandemic on the 11th of March
2020, but the world is still reeling from its aftermath. Originating from China, cases quickly …
2020, but the world is still reeling from its aftermath. Originating from China, cases quickly …
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo …
…, M Foszczynska-Kloda, S Franco, H Fujii… - The Lancet …, 2020 - thelancet.com
Background CLEOPATRA was a phase 3 study comparing the efficacy and safety of pertuzumab,
trastuzumab, and docetaxel with placebo, trastuzumab, and docetaxel in patients with …
trastuzumab, and docetaxel with placebo, trastuzumab, and docetaxel in patients with …